Mucosal immune responses to infection and vaccination in the respiratory tract

RC Mettelman, EK Allen, PG Thomas - Immunity, 2022 - cell.com
The lungs are constantly exposed to inhaled debris, allergens, pollutants, commensal or
pathogenic microorganisms, and respiratory viruses. As a result, innate and adaptive …

Mucosal vaccination: Onward and upward

CJY Tsai, JMS Loh, K Fujihashi… - Expert Review of …, 2023 - Taylor & Francis
Introduction The unique mucosal immune system allows the generation of robust protective
immune responses at the front line of pathogen encounters. The needle-free delivery route …

STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant

MD Gallovic, RD Junkins, AM Sandor, ES Pena… - Journal of Controlled …, 2022 - Elsevier
The current pandemic highlights the need for effective vaccines against respiratory viruses.
An ideal vaccine should induce robust and long-lasting responses with high manufacturing …

Vinyl sulfone-functionalized acetalated dextran microparticles as a subunit broadly acting influenza vaccine

CJ Batty, LM Lifshits, DA Hendy, M Eckshtain-Levi… - The AAPS journal, 2023 - Springer
Influenza is a global health concern with millions of infections occurring yearly. Seasonal flu
vaccines are one way to combat this virus; however, they are poorly protective against …

cGAMP the travelling messenger

HTW Blest, L Chauveau - Frontiers in Immunology, 2023 - frontiersin.org
2'3'-cGAMP is a key molecule in the cGAS-STING pathway. This cyclic dinucleotide is
produced by the cytosolic DNA sensor cGAS in response to the presence of aberrant dsDNA …

Hydrogels for Mucosal Drug Delivery

T Yeruva, S Yang, S Doski… - ACS Applied Bio Materials, 2023 - ACS Publications
Mucosal tissues are often a desirable site of drug action to treat disease and engage the
immune system. However, systemically administered drugs suffer from limited bioavailability …

PCP consensus protein/peptide alphavirus antigens stimulate broad spectrum neutralizing antibodies

CH Schein, G Rafael, WS Baker, ES Anaya… - Peptides, 2022 - Elsevier
Vaccines based on proteins and peptides may be safer and if calculated based on many
sequences, more broad-spectrum than those designed based on single strains …

Nasal Vaccine for the Control of Emerging Variants of SARS-CoV-2

A Kumar, DA Vaghela, PC Balar… - SARS-CoV-2 Variants …, 2024 - taylorfrancis.com
SARS-CoV-2 has become a global pandemic. It has made the healthcare system vulnerable
and has put pressure on it to be updated in a hurry. SARS-CoV-2 has altered itself at …

Peptide and protein alphavirus antigens for broad spectrum vaccine design

CH Schein, G Rafael, WS Baker, ES Anaya… - bioRxiv, 2022 - biorxiv.org
Vaccines based on proteins and peptides may be safer and more broad-spectrum than other
approaches Physicochemical property consensus (PCPcon) alphavirus antigens from the B …